Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV inf (Q45749397)
Jump to navigation
Jump to search
scientific article published in May 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV inf |
scientific article published in May 1999 |
Statements
1 reference
Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV inf (English)
1 reference
S Plotkin
1 reference
D Salmon-Céron
1 reference
J L Excler
1 reference
L Finkielsztejn
1 reference
B Autran
1 reference
J C Gluckman
1 reference
D Sicard
1 reference
T J Matthews
1 reference
B Meignier
1 reference
C Valentin
1 reference
R El Habib
1 reference
C Blondeau
1 reference
M Raux
1 reference
C Moog
1 reference
J Tartaglia
1 reference
P Chong
1 reference
M Klein
1 reference
B Milcamps
1 reference
F Heshmati
1 reference
1 May 1999
1 reference
15
1 reference
7
1 reference
633-645
1 reference
Identifiers
1 reference
1 reference